Skip to main content
Fuji Pharma Co.,Ltd. logo

Fuji Pharma Co.,Ltd. — Investor Relations & Filings

Ticker · 4554 ISIN · JP3816200004 LEI · 529900L1XVCEHVKHAM60 T Manufacturing
Open in API
Filings indexed 65 across all filing types
Latest filing 2016-12-21 Annual Report
Country JP Japan
Listing T 4554

About Fuji Pharma Co.,Ltd.

https://www.fujipharma.jp/english/ir/

Fuji Pharma Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of prescription medical products. The company's primary focus is on women's healthcare, including hormonal preparations for obstetrics and gynecology, alongside curative medicines and in-vitro diagnostics. Its portfolio includes both specialty and generic drugs. In addition to developing its own pharmaceuticals, Fuji Pharma offers extensive contract manufacturing services for a wide variety of dosage forms, such as solids, injections, ointments, creams, and liquids, for domestic and international clients.

Recent filings

Filing Released Lang Actions
有価証券報告書－第52期(2015/10/01－2016/09/30)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains comprehensive financial statements, management discussion, and business overview for the fiscal year ending September 30, 2016. It is a full annual report, not an announcement or a summary. FY 2016
2016-12-21 Japanese
四半期報告書－第52期第3四半期(2016/04/01－2016/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Fuji Pharma Co., Ltd. covering the third quarter of the 52nd fiscal year (April 1, 2016, to June 30, 2016). It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement, as well as notes on accounting policies. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2016
2016-08-10 Japanese
四半期報告書－第52期第2四半期(2016/01/01－2016/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed under the Financial Instruments and Exchange Act of Japan. It contains comprehensive financial statements, including the balance sheet, income statement, and cash flow statement for the second quarter of the 52nd fiscal period. It is a formal regulatory filing containing substantive financial data, not merely an announcement or certification, thus fitting the definition of an Interim/Quarterly Report. Q2 2016
2016-05-13 Japanese
四半期報告書－第52期第1四半期(2015/10/01－2015/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Fuji Pharma Co., Ltd., covering the first quarter of the 52nd fiscal period (October 1, 2015, to December 31, 2015). It contains detailed financial statements, including the consolidated balance sheet, income statement, and comprehensive income statement, along with notes to the financial statements. This meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. Q1 2016
2016-02-10 Japanese
有価証券報告書－第51期(2014/10/01－2015/09/30)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains detailed financial statements, management discussion, and corporate information for the fiscal year ending September 30, 2015. The document header explicitly identifies it as a 'Securities Report' (有価証券報告書) submitted under the Financial Instruments and Exchange Act. FY 2015
2015-12-18 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.